Richard Sun

Title: Richard Sun: Innovator in Cancer Treatment

Introduction

Richard Sun is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on the administration of estrogen receptor antagonists, which play a crucial role in combating cancer.

Latest Patents

Richard Sun holds a patent for "Regimens of estrogen receptor antagonists." This patent outlines methods for administering estrogen receptor antagonists for the treatment of cancer. In particular, the patent details the use of tetrahydro pyrido[3,4-b] indole compounds as complete estrogen receptor antagonists. This innovative approach has the potential to improve treatment outcomes for cancer patients.

Career Highlights

Richard Sun is currently employed at Olema Pharmaceuticals, Inc., where he continues to advance his research in cancer therapies. His dedication to innovation in this field has positioned him as a key figure in the development of new treatment methodologies.

Collaborations

Richard has collaborated with esteemed colleagues such as Cyrus L. Harmon and Peter J. Kushner. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Richard Sun's contributions to cancer treatment through his patent and work at Olema Pharmaceuticals, Inc. highlight his commitment to innovation in the medical field. His research on estrogen receptor antagonists represents a significant advancement in cancer therapy.